Financhill
Buy
62

MNKD Quote, Financials, Valuation and Earnings

Last price:
$5.94
Seasonality move :
-4.4%
Day range:
$5.84 - $6.02
52-week range:
$3.38 - $7.04
Dividend yield:
0%
P/E ratio:
63.59x
P/S ratio:
5.89x
P/B ratio:
--
Volume:
3M
Avg. volume:
3.3M
1-year change:
-15.53%
Market cap:
$1.8B
Revenue:
$285.5M
EPS (TTM):
$0.09

Analysts' Opinion

  • Consensus Rating
    MannKind Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $9.61, MannKind Corp. has an estimated upside of 60.45% from its current price of $5.93.
  • Price Target Downside
    According to analysts, the lowest downside price target is $7.50 representing 100% downside risk from its current price of $5.93.

Fair Value

  • According to the consensus of 8 analysts, MannKind Corp. has 60.45% upside to fair value with a price target of $9.61 per share.

MNKD vs. S&P 500

  • Over the past 5 trading days, MannKind Corp. has underperformed the S&P 500 by -1.46% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • MannKind Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • MannKind Corp. has grown year-over-year revenues for 13 quarters straight. In the most recent quarter MannKind Corp. reported revenues of $82.1M.

Earnings Growth

  • MannKind Corp. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter MannKind Corp. reported earnings per share of $0.03.
Enterprise value:
1.8B
EV / Invested capital:
9.95x
Price / LTM sales:
5.89x
EV / EBIT:
23.66x
EV / Revenue:
5.75x
PEG ratio (5yr expected):
1.86x
EV / Free cash flow:
42.24x
Price / Operating cash flow:
43.26x
Enterprise value / EBITDA:
20.77x
Gross Profit (TTM):
$235.9M
Return On Assets:
6.72%
Net Income Margin (TTM):
9.32%
Return On Equity:
--
Return On Invested Capital:
24.75%
Operating Margin:
22.86%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $176.5M $267.2M $313.8M $70.1M $82.1M
Gross Profit $115.7M $192.1M $235.9M $52.1M $61.9M
Operating Income -$9.4M $57.3M $76.3M $15.2M $18.8M
EBITDA -$3.8M $65.1M $86.9M $17.8M $21.5M
Diluted EPS -$0.12 $0.07 $0.09 $0.04 $0.03
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $159.2M $218.4M $225.6M $327.7M $358.8M
Total Assets $238.2M $293.8M $320.3M $464.2M $494.6M
Current Liabilities $50M $59.6M $96.4M $72.1M $109.1M
Total Liabilities $422.9M $531.5M $572.1M $674.1M $539.2M
Total Equity -$184.7M -$237.7M -$251.8M -$209.9M -$44.6M
Total Debt $287.5M $383.6M $382.4M $344.9M $187.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $9.9M $41.2M $48.2M $9.3M $23.5M
Cash From Investing $20.9M -$152.8M $35.4M -$41.3M -$25.1M
Cash From Financing -$2.1M $91.6M -$18.6M -$2.3M $72M
Free Cash Flow -$31.8M $28.5M $42.7M $7.8M $22.4M
MNKD
Sector
Market Cap
$1.8B
$28.4M
Price % of 52-Week High
85.09%
51.17%
Dividend Yield
0%
0%
Shareholder Yield
1.42%
-1.49%
1-Year Price Total Return
-12.56%
-16.67%
Beta (5-Year)
0.821
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $5.94
200-day SMA
Buy
Level $4.78
Bollinger Bands (100)
Buy
Level 4.47 - 5.85
Chaikin Money Flow
Sell
Level -318.6M
20-day SMA
Buy
Level $5.73
Relative Strength Index (RSI14)
Buy
Level 61.48
ADX Line
Buy
Level 35.49
Williams %R
Neutral
Level -23.8095
50-day SMA
Buy
Level $5.50
MACD (12, 26)
Buy
Level 0.16
25-day Aroon Oscillator
Buy
Level 80
On Balance Volume
Neutral
Level 219.3M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-7.0402)
Sell
CA Score (Annual)
Level (-3.5074)
Sell
Beneish M-Score (Annual)
Level (-1.1939)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (3.5596)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Stock Forecast FAQ

In the current month, MNKD has received 8 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MNKD average analyst price target in the past 3 months is $9.61.

  • Where Will MannKind Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that MannKind Corp. share price will rise to $9.61 per share over the next 12 months.

  • What Do Analysts Say About MannKind Corp.?

    Analysts are divided on their view about MannKind Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MannKind Corp. is a Sell and believe this share price will drop from its current level to $7.50.

  • What Is MannKind Corp.'s Price Target?

    The price target for MannKind Corp. over the next 1-year time period is forecast to be $9.61 according to 8 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MNKD A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for MannKind Corp. is a Buy. 8 of 8 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of MNKD?

    You can purchase shares of MannKind Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MannKind Corp. shares.

  • What Is The MannKind Corp. Share Price Today?

    MannKind Corp. was last trading at $5.94 per share. This represents the most recent stock quote for MannKind Corp.. Yesterday, MannKind Corp. closed at $5.93 per share.

  • How To Buy MannKind Corp. Stock Online?

    In order to purchase MannKind Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.

Buy
60
ZBIO alert for Dec 23

Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.

Buy
54
UNF alert for Dec 23

UniFirst Corp. [UNF] is up 0.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock